ORIG3N: Boston startup Orig3n logged hundreds of false-positives as it processed COVID tests for dozens of long-term care facilities. Now, the company is under investigation
According to an Orig3n spokesman, the company continues to offer COVID-19 testing elsewhere in the U.S.
Read full article »
ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications.
Read more